We are live on ! Find out more
PRAX icon

Praxis Precision Medicines
PRAX

60 hedge funds and large institutions have $179M invested in Praxis Precision Medicines in 2023 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 13 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

25,100% more call options, than puts

Call options by funds: $252K | Put options by funds: $1K

146% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 13

87.8% more ownership

Funds ownership: 5.93% → 93.73% (+88%)

9% less capital invested

Capital invested by funds: $196M → $179M (-$16.7M)

19% less funds holding

Funds holding: 74 → 60 (-14)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

58% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 24

Holders
60
Holders Change
-14
Holders Change %
-18.92%
% of All Funds
0.87%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
10
Increased
32
Reduced
13
Closed
24
Calls
$252K
Puts
$1K
Net Calls
+$251K
Net Calls Change
+$106K

Top Buyers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.76M
2
Verition Fund Management
Verition Fund Management
Connecticut
+$1.78M
3
PHS
PFM Health Sciences
California
+$1.11M
4
CIBC Asset Management
CIBC Asset Management
Ontario, Canada
+$939K
5
IC
Ikarian Capital
Texas
+$901K

Top Sellers

1
VVA
Vida Ventures Advisors
Massachusetts
-$2.51M
2
SCM
Soleus Capital Management
Connecticut
-$1.97M
3
TLP
Tri Locum Partners
New York
-$1.35M
4
ACM
Altium Capital Management
New York
-$1.11M
5
SSA
Schonfeld Strategic Advisors
New York
-$1.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
Simplex Trading
51
Simplex Trading
Illinois
$31K +$25.1K +1,392 New
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
$26K +$20.8K +1,157 New
FFA
53
Farther Finance Advisors
California
$22.3K – – –
Group One Trading
54
Group One Trading
Illinois
$3.56K -$306 -17 -10%
Deutsche Bank
55
Deutsche Bank
Germany
$3.39K -$18 -1 -0.7%
RhumbLine Advisers
56
RhumbLine Advisers
Massachusetts
$3.39K – – –
Fidelity Investments
57
Fidelity Investments
Massachusetts
$2.56K -$234 -13 -10%
Wells Fargo
58
Wells Fargo
California
$1.49K +$72 +4 +6%
JP Morgan Chase
59
JP Morgan Chase
New York
$379 -$1.46K -81 -83%
VVA
60
Vida Ventures Advisors
Massachusetts
– -$2.51M -97,978 Closed
SCM
61
Soleus Capital Management
Connecticut
– -$1.97M -76,667 Closed
ACM
62
Altium Capital Management
New York
– -$1.11M -43,333 Closed
SSA
63
Schonfeld Strategic Advisors
New York
– -$1.08M -42,170 Closed
Goldman Sachs
64
Goldman Sachs
New York
– -$158K -6,174 Closed
Bank of New York Mellon
65
Bank of New York Mellon
New York
– -$128K -5,005 Closed
PI
66
PEAK6 Investments
Illinois
– -$110K -4,298 Closed
Principal Financial Group
67
Principal Financial Group
Iowa
– -$59.3K -2,310 Closed
GCP
68
GSA Capital Partners
United Kingdom
– -$57K -2,237 Closed
JF
69
Jump Financial
Illinois
– -$55.8K -2,177 Closed
AWA
70
Alta Wealth Advisors
Massachusetts
– -$53.1K -2,069 Closed
PWA
71
PCG Wealth Advisors
Kansas
– -$50.4K -1,967 Closed
Charles Schwab
72
Charles Schwab
California
– -$36.2K -1,410 Closed
Prudential Financial
73
Prudential Financial
New Jersey
– -$28.6K -1,113 Closed
Neuberger Berman Group
74
Neuberger Berman Group
New York
– -$27.5K -1,071 Closed
Two Sigma Advisers
75
Two Sigma Advisers
New York
– -$26.8K -1,047 Closed
1 2
3
4

PRAX Hedge Fund Activity: Q4 2023 in Review

60 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Praxis Precision Medicines (PRAX) for Q4 2023, worth a combined $179M — down 8.5% from $196M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of PRAX and 10 opened new positions — a net loss of 14 holders — while 13 trimmed existing stakes and 32 added.

The largest buyer was Adage Capital Partners, adding an estimated $2.76M. The largest seller was Vida Ventures Advisors, exiting entirely with an estimated $2.51M sold.

  • 60 institutional investors held Praxis Precision Medicines (PRAX) as of Q4 2023, down from 74 in Q3 2023.
  • Funds reported $179M of Praxis Precision Medicines stock for Q4 2023, down 8.5% quarter-over-quarter.
  • 10 funds opened new Praxis Precision Medicines positions in Q4 2023 and 24 closed out, a net change of -14 holders.
  • The largest Praxis Precision Medicines buyer in Q4 2023 was Adage Capital Partners, an estimated $2.76M added.
  • The largest Praxis Precision Medicines seller in Q4 2023 was Vida Ventures Advisors, an estimated $2.51M sold.

Based on aggregated 13F filings for Q4 2023.